Form4insider filings, from the source

SEC Form 4 · accession 0001140361-17-027467

Organogenesis Holdings Inc. · ORGO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owners
Thompson Dean
Officer — Executive Chairman · Director · 10% Owner
David F Burgstahler
Officer — President and CEO · Director · 10% Owner
Period of report
Jul 5, 2017
Accepted (ET)
Jul 7, 2017 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001661181

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Class B Ordinary SharesF2,F3,F4,F1—Nov 28, 2016S186,320D——Class A Ordinary Shares186,3205,792,500D

Explanation of responses

Remarks

Exhibit 99.1 Joint Filer Information, incorporated herein by reference.